Imikeraderm,

Imiquimod, the active ingredient in Imikeraderm, is an immune response modifier presented as a topical cream for cutaneous use. It is prescribed for the treatment of certain skin lesions, including actinic keratosis, superficial basal cell carcinoma, and external genital warts, in adult patients.

GNH USA supplies Imikeraderm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Imikeraderm, a topical immunomodulator, is used to manage skin conditions that involve abnormal cell growth or viral infection. - Actinic keratosis: clears precancerous lesions and reduces progression to squamous cell carcinoma. - Superficial basal cell carcinoma: promotes tumor regression in early‑stage basal cell skin cancer. - External genital warts: induces immune‑mediated clearance of human papillomavirus–related lesions.

Adverse reactions may occur at the application site or systemically.

Common Side Effects: - Erythema: localized redness at the treated area. - Pruritus: itching of the skin where the cream is applied. - Burning sensation: transient heat or stinging feeling. - Dryness or scaling: flaking of the skin surface. - Edema: mild swelling of the treated region.

Serious or Rare Side Effects: - Severe dermatitis: extensive skin inflammation requiring medical attention. - Contact urticaria: hives or allergic skin reaction. - Systemic flu‑like symptoms: fever, chills, or malaise. - Secondary infection: bacterial or fungal infection of the lesion site.

Before using Imikeraderm, consider the following safety measures. - Contraindication: Do not apply to immunocompromised patients without specialist advice. - Pregnancy: Avoid use during pregnancy unless the potential benefit justifies the risk. - Breastfeeding: Discontinue if nursing, as safety has not been established. - Application area: Limit use to prescribed skin lesions; avoid mucous membranes and open wounds. - Monitoring: Observe for signs of severe local reaction or infection and seek medical care if they occur. - Store at room temperature: keep the tube in the original packaging, protect from moisture and direct sunlight.

Imikeraderm may interact with other topical agents or systemic immunomodulators.

Major Interactions (Avoid): - Concurrent use with other topical irritants (e.g., retinoids) that may exacerbate skin inflammation. - Systemic immunosuppressants (e.g., cyclosporine) that could diminish therapeutic effect.

Moderate Interactions (Monitor Closely):\n- Topical corticosteroids: may reduce efficacy if used simultaneously. - Antiviral medications: monitor for altered local immune response. - Phototherapy: increased risk of skin irritation when combined.